Antibacterial peptide that inhibits reference strains of both Gram-negative bacteria (E.coli, P.aeruginosa, E.cloacae, K.pneumoniae, and A.actinomycetemcomitans) and Gram-positive bacteria (S.aureus) with relatively low potencies (MIC=25-400 uM) (PubMed:28115922) (By similarity). Shows antifungal activity against C.lusitaniae (MIC=50.25 uM), but no activity against C.albicans (PubMed:28115922). In the presence of an alkaloid (bufotenine), inhibits cellular infection by the rabies virus (PubMed:26635873). The peptide shows very low hemolytic activity against rabbit erythrocytes (PubMed:28115922) (By similarity). The low amphipathicity of alpha-helices demonstrated by wheel projection as well as the low cationicity may explain the low antibacterial and hemolytic potencies (By similarity). Expressed by the skin glands. The primary structure of this peptide is identical to that of Ocellatin-F1 from Leptodactylus fallax (AC P0DQJ8). Belongs to the frog skin active peptide (FSAP) family. Ocellatin subfamily.